Cleared Traditional

OVision Imaging System (K200275) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200275 · Ophthalmic Labs, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
28d
Days
Class 2
Risk

K200275 is an FDA 510(k) clearance for the OVision Imaging System. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Ophthalmic Labs, Inc. (Milton, US). The FDA issued a Cleared decision on March 3, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ophthalmic Labs, Inc. devices

Submission Details

510(k) Number K200275 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2020
Decision Date March 03, 2020
Days to Decision 28 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 110d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
DAVE YUNGVIRT

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 51
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K200275.
Harmony Referral System with Harmony OCT Viewer (Octave)
K253893 · Topcon Healthcare Solutions EMEA Oy · Jun 2026
iCare ALTIUS CW
K234076 · Centervue S.P.A. · Aug 2024
IMAGEnet6 Ophthalmic Data System
K232828 · Topcon Corporation · Mar 2024
CALLISTO eye
K232944 · Carl Zeiss Meditec, AG · Dec 2023
Harmony
K232555 · Topcon Healthcare Solutions · Nov 2023
CALLISTO eye
K231676 · Carl Zeiss Meditec, AG · Aug 2023